… (GLOBE NEWSWIRE) — Histogenics Corporation (Nasdaq: HSGX) and Ocugen, Inc., a … call. About Histogenics Corporation Histogenics (Nasdaq: HSGX) develops restorative cell therapies … combined company’s listing on Nasdaq after closing of the proposed …
Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics
Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics
{$excerpt:n}